Testing effectiveness (Phase 2)Study completedNCT00839163
What this trial is testing
Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Who this might be right for
Venous ThrombosisDeep Vein Thrombosis
Bayer 613